Antiplatelet drugs after acute myocardial infarction

Research output: Contribution to journalArticlepeer-review


Some considerations on the rationale for the use of antiplatelet drugs after acute myocardial infarction are reviewed and attention is drawn to the importance of using the results of clinical trials in the choice of the available drugs. Particular attention is focused on the advisability of using the dosages and the drugs evaluated in such trials, without following the current fashion of selecting new drugs or arbitrary dosage regimens of the old drugs.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalLa Ricerca in Clinica e in Laboratorio
Issue number1
Publication statusPublished - Jan 1984


  • Acetylsalicylic acid
  • Antiplatelet drugs
  • Dipyridamole
  • Myocardial infarction
  • Sulfinpyrazone

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Antiplatelet drugs after acute myocardial infarction'. Together they form a unique fingerprint.

Cite this